These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 3124857)

  • 1. Kinetic and inhibitor studies of 4-methylumbelliferone and 1-naphthol glucuronidation in human liver microsomes.
    Miners JO; Lillywhite KJ; Matthews AP; Jones ME; Birkett DJ
    Biochem Pharmacol; 1988 Feb; 37(4):665-71. PubMed ID: 3124857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic modeling of the interactions between 4-methylumbelliferone, 1-naphthol, and zidovudine glucuronidation by udp-glucuronosyltransferase 2B7 (UGT2B7) provides evidence for multiple substrate binding and effector sites.
    Uchaipichat V; Galetin A; Houston JB; Mackenzie PI; Williams JA; Miners JO
    Mol Pharmacol; 2008 Oct; 74(4):1152-62. PubMed ID: 18647858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid.
    Uchaipichat V; Mackenzie PI; Guo XH; Gardner-Stephen D; Galetin A; Houston JB; Miners JO
    Drug Metab Dispos; 2004 Apr; 32(4):413-23. PubMed ID: 15039294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evidence for the involvement of at least two forms of human liver UDP-glucuronosyltransferase in morphine 3-glucuronidation.
    Miners JO; Lillywhite KJ; Birkett DJ
    Biochem Pharmacol; 1988 Jul; 37(14):2839-45. PubMed ID: 3134892
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of mutations associated with Gilbert and Crigler-Najjar type II syndromes on the glucuronidation kinetics of bilirubin and other UDP-glucuronosyltransferase 1A substrates.
    Udomuksorn W; Elliot DJ; Lewis BC; Mackenzie PI; Yoovathaworn K; Miners JO
    Pharmacogenet Genomics; 2007 Dec; 17(12):1017-29. PubMed ID: 18004206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of paracetamol UDP-glucuronosyltransferase activity in human liver microsomes.
    Miners JO; Lillywhite KJ; Yoovathaworn K; Pongmarutai M; Birkett DJ
    Biochem Pharmacol; 1990 Aug; 40(3):595-600. PubMed ID: 2116803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The "albumin effect" and drug glucuronidation: bovine serum albumin and fatty acid-free human serum albumin enhance the glucuronidation of UDP-glucuronosyltransferase (UGT) 1A9 substrates but not UGT1A1 and UGT1A6 activities.
    Rowland A; Knights KM; Mackenzie PI; Miners JO
    Drug Metab Dispos; 2008 Jun; 36(6):1056-62. PubMed ID: 18362158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of UDP-glucuronosyltransferase activity by possible transition-state analogues in rat-liver microsomes.
    Noort D; Coughtrie MW; Burchell B; van der Marel GA; van Boom JH; van der Gen A; Mulder GJ
    Eur J Biochem; 1990 Mar; 188(2):309-12. PubMed ID: 2108023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that unsaturated fatty acids are potent inhibitors of renal UDP-glucuronosyltransferases (UGT): kinetic studies using human kidney cortical microsomes and recombinant UGT1A9 and UGT2B7.
    Tsoutsikos P; Miners JO; Stapleton A; Thomas A; Sallustio BC; Knights KM
    Biochem Pharmacol; 2004 Jan; 67(1):191-9. PubMed ID: 14667942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on tertiary amine UDP-glucuronosyltransferases from human and rabbit hepatic microsomes.
    Styczynski PB; Green MD; Coffman B; Tephly TR
    Drug Metab Dispos; 1992; 20(6):896-901. PubMed ID: 1362943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucuronidation and sulfation in the rat in vivo. The role of the liver and the intestine in the in vivo clearance of 4-methylumbelliferone.
    Mulder GJ; Brouwer S; Weitering JG; Scholtens E; Pang KS
    Biochem Pharmacol; 1985 Apr; 34(8):1325-9. PubMed ID: 3994749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective and potent inhibition of different hepatic UDP-glucuronosyltransferase activities by omega,omega,omega-triphenylalcohols and UDP derivatives.
    Said M; Noort D; Magdalou J; Ziegler JC; van der Marel GA; van Boom JH; Mulder GJ; Siest G
    Biochem Biophys Res Commun; 1992 Aug; 187(1):140-5. PubMed ID: 1520294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of UDP-glucuronosyltransferase activity toward digitoxigenin-monodigitoxoside in neonatal rats.
    Watkins JB; Klaassen CD
    Drug Metab Dispos; 1985; 13(2):186-91. PubMed ID: 2859166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro N-glucuronidation of SB 47436 (BMS 186295), a new AT1 nonpeptide angiotensin II receptor antagonist, by rat, monkey and human hepatic microsomal fractions.
    Perrier L; Bourrié M; Marti E; Tronquet C; Massé D; Berger Y; Magdalou J; Fabre G
    J Pharmacol Exp Ther; 1994 Oct; 271(1):91-9. PubMed ID: 7965761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucuronidation of 2-arylpropionic acids pirprofen, flurbiprofen, and ibuprofen by liver microsomes.
    Magdalou J; Chajes V; Lafaurie C; Siest G
    Drug Metab Dispos; 1990; 18(5):692-7. PubMed ID: 1981722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential induction of human liver UDP-glucuronosyltransferase activities by phenobarbital-type inducers.
    Bock KW; Bock-Hennig BS
    Biochem Pharmacol; 1987 Dec; 36(23):4137-43. PubMed ID: 2825716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Similarities and differences in the glucuronidation of estradiol and estrone by UDP-glucuronosyltransferase in liver microsomes from male and female rats.
    Zhu BT; Suchar LA; Huang MT; Conney AH
    Biochem Pharmacol; 1996 May; 51(9):1195-202. PubMed ID: 8645343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UDP-glucuronyltransferase in perfused rat liver and in microsomes. Effects of CCl4 injury.
    Bock KW; Huber E; Schlote W
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Feb; 296(3):199-203. PubMed ID: 402587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of microsomal uridine diphosphate glucuronyltransferase by glucuronic acid derivatives.
    Vessey DA; Zakim D
    Biochem J; 1974 Apr; 139(1):243-9. PubMed ID: 4219139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Product inhibition of UDP-glucuronosyltransferase (UGT) enzymes by UDP obfuscates the inhibitory effects of UGT substrates.
    Fujiwara R; Nakajima M; Yamanaka H; Katoh M; Yokoi T
    Drug Metab Dispos; 2008 Feb; 36(2):361-7. PubMed ID: 17998297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.